4Filed Sep 15, 8:00 PM ET

Recursion (RXRX) CFO Ben R. Taylor Withholds 5,396 Shares for Taxes

$RXRX · RECURSION PHARMACEUTICALS, INC.

Research Summary

AI-generated summary of this SEC filing

Updated

Recursion (RXRX) CFO Ben R. Taylor Withholds 5,396 Shares for Taxes

What Happened Ben R. Taylor, Chief Financial Officer of Recursion Pharmaceuticals, had 5,396 shares withheld by the company to satisfy tax withholding obligations in connection with the net settlement of restricted stock units (RSUs). The shares were accounted at $3.41 per share, for an aggregate value of approximately $18,400. This is a routine tax-withholding disposition related to equity compensation, not an open-market sale or purchase.

Key Details

  • Transaction date: 2026-09-15
  • Price per share: $3.41; Total value: ~$18,400
  • Transaction type/code: Tax withholding/net settlement of RSUs (Code F)
  • Footnote: F1 — shares were withheld by the issuer to satisfy tax withholding and remittance obligations for net-settled RSUs
  • Filing: Form 4 filed 2026-09-16 (one day after the transaction) — appears timely
  • Shares owned after transaction: Not specified in the provided summary filing details

Context Withholdings to cover taxes on RSU vesting are common and typically reflect routine administrative actions rather than a deliberate sale by the insider. This transaction reduces the insider’s share count but does not necessarily indicate a change in their view of the company.